Vimarsana
Biggest News Aggregation in the World

Page 23 - Pharma Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Plc Today - Breaking & Trending Today

N4 Pharma EPO has now formally granted European Patent - DirectorsTalk Interviews - Vimarsana News

N4 Pharma EPO has now formally granted European Patent - DirectorsTalk Interviews

N4 Pharma EPO has now formally granted European Patent

N4 Pharma Plc Regulatory News. Live N4P RNS. Regulatory News Articles for N4 Pharma Plc Ord 0.4P - Vimarsana News

N4 Pharma Plc Regulatory News. Live N4P RNS. Regulatory News Articles for N4 Pharma Plc Ord 0.4P

N4 Pharma Plc Regulatory News. Live N4P RNS. Regulatory News Articles for N4 Pharma Plc Ord 0.4P

Source: lse.co.uk
Human Microbiome Therapeutics Market to register USD 516.08 mn growth during 2021-2025 - Vimarsana News

Human Microbiome Therapeutics Market to register USD 516.08 mn growth during 2021-2025

/PRNewswire/ -- The human microbiome therapeutics market will grow by USD 516.08 million from 2021 to 2025, while registering a CAGR of 47.79%, as per...

Herantis Pharma: Results for the First Half Year January 1 - June 30, 2021 - Vimarsana News

Herantis Pharma: Results for the First Half Year January 1 - June 30, 2021

Herantis Pharma Plc Company Release August 26, 2021, at 9:00 a.m. EEST/8:00 a.m. CEST Dr. Craig Cook CEO of Herantis commented: In 2021, Herantis continued to optimize its assets and shape the... | August 27, 2021

Investegate |Adams PLC Announcements | Adams PLC: Final Results - Vimarsana News

Investegate |Adams PLC Announcements | Adams PLC: Final Results

-  Net assets per share 6.24 pence at 31 March 2021 (2020: 2.50 pence). -  Profit after tax of £3.09 million (2020: loss £0.30 million). -  Investments at 31 March 2021 valued at £5.11 million (2020: £1.18 million). -  Spend on new investments of £1.90 million (2020: £1.38 million).   -  Investment realisation proceeds of £1.21 million (2020: £2.03 million). -  Cash at 31 March 2021 of £0.05 million (2020: £0.90 million). -  Post year end raised...